AOD-9604

• 5mg lyophilized peptide
• Dry-fill capsules (100mcg each / 60ct / 6mg total)

• Stimulates lipolysis by promoting the release of fatty acids from adipose tissue, mimicking fat burning signals associated with growth hormone
• Supports regulation of fat metabolism by promoting fat cell breakdown while minimizing fat storage signaling
• Acts as a GH fragment specific approach, targeting fat loss pathways while avoiding many systemic growth promoting effects linked to full length HGH

AOD-9604 is being explored in research involving

• Targeted fat reduction, especially in stubborn areas such as the abdominal region
• Lan mass preservation signals while emphasizing fat loss outcomes
• Supportive component in a broader weight management approach focused on improving overall body composition

AOD-9604 is commonly described as well tolerated with few side effects reported in research settings. Minor temporary reactions such as redness or irritation at the injection site may occur. Individual response can vary, so conservative ramp up and monitoring are typically recommended in real world contexts.

• Synergistic with glp-1s such as Reta, Tirz, Sema within the context of fat loss research
• Synergistic with growth hormone secretagogues such as Tesamorelin, Ipamorelin, CJC-1295 for further lipolysis.